Assessment of the number of CD11b+ cells present within the viable tumour portion of the sections (Fig 6F and G) showed a significant reduction in the levels of these cells, in mice which had received adjuvant AZD5363 (adjusted P = 0.0004; Fig 6G) when compared to those that had received RT alone. This evidence concerns the gene ITGAM and neoplasm.